Patient-Reported Outcomes in Children with Moderately to Severely Active Polyarticular or Polyarticular-Course Juvenile Idiopathic Arthritis Who Are Prescribed and Treated with Adalimumab.

被引:0
|
作者
Horneff, Gerd [1 ]
Wallace, Carol A. [2 ,3 ]
Quartier, Pierre [4 ]
Kingsbury, Daniel J. [5 ]
Minden, Kirsten [6 ]
Bereswill, Mareike [7 ]
Garg, Vishvas [8 ]
Kupper, Hartmut [7 ]
Kalabic, Jasmina [7 ]
机构
[1] Asklepios Klin Sankt Augustin, St Augustin, Germany
[2] Univ Washington, Sch Med, Seattle, WA USA
[3] Seattle Childrens Hosp, Seattle, WA USA
[4] Univ Paris 05, Hop Necker Enfants Malad, AP HP, IMAGINE Inst, Paris, France
[5] Randall Childrens Hosp Legacy Emanuel, Portland, OR USA
[6] Kinderklin Charite, Otto Heubner Ctr, Berlin, Germany
[7] AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany
[8] AbbVie Inc, N Chicago, IL USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
289
引用
收藏
页码:S122 / S123
页数:2
相关论文
共 40 条
  • [1] LONG-TERM SAFETY AND EFFECTIVENESS OF ADALIMUMAB IN CHILDREN WITH MODERATELY TO SEVERELY ACTIVE POLYARTICULAR OR POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS
    Horneff, G.
    Ruperto, N.
    Wallace, C.
    Bereswill, M.
    Cardoso, A.
    Kalabic, J.
    Kupper, H.
    Brunner, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 61 - 62
  • [2] LONG-TERM SAFETY AND EFFECTIVENESS OF ADALIMUMAB IN CHILDREN WITH MODERATELY TO SEVERELY ACTIVE POLYARTICULAR OR POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS Abstracts
    Ruperto, N.
    Brunner, H.
    Wallace, C.
    Toth, M.
    Foeldvari, I.
    Bohnsack, J.
    Milojevic, D.
    Rabinovich, E.
    Vavrincova, P.
    Kingsbury, D.
    Marzan, K.
    Quartier, P.
    Minden, K.
    Chalom, E.
    Horneff, G.
    Kuester, R. -M.
    Dare, J.
    Bereswill, M.
    Kupper, H.
    Kalabic, J.
    Martini, A.
    Lovell, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 92 - 93
  • [3] Long-Term Safety and Effectiveness of Adalimumab in Children with Moderately to Severely Active Polyarticular or Polyarticular-Course Juvenile Idiopathic Arthritis.
    Brunner, Hermine
    Ruperto, Nicola
    Wallace, Carol A.
    Toth, Mary
    Foeldvari, Ivan
    Bohnsack, John
    Milojevic, Diana
    Rabinovich, C. Egla
    Vavrincova, Pavla
    Kingsbury, Daniel J.
    Marzan, Katherine
    Quartier, Pierre
    Minden, Kirsten
    Chalom, Elizabeth
    Horneff, Gerd
    Kuester, Rolf M.
    Dare, Jason
    Bereswill, Mareike
    Kupper, Hartmut
    Kalabic, Jasmina
    Lovell, Daniel
    Martini, Alberto
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S115 - S116
  • [4] GROWTH AND DEVELOPMENT OF PATIENTS WITH POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH SUBCUTANEOUS ABATACEPT
    Ruperto, Nicolino
    Brunner, Hermine
    Cornejo, Gabriel Vega
    Berman, Alberto
    Anton, Jordi
    Cuttica, Ruben
    Keltsev, Vladimir
    Viola, Diego Oscar
    Lauwerys, Bernard
    Rama, Maria Elena
    Bohnsack, John
    Caillaud, Caroline
    Minden, Kirsten
    Ally, Mahmood Moosa
    Gervais, Elisabeth
    Van Zyl, Riana
    Gandhi, Yash
    Murthy, Bindu
    Nys, Marleen
    Wong, Robert
    Hoang, Jade
    Martini, Alberto
    Lovell, Daniel J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1347 - 1348
  • [5] IDENTIFICATION OF OPTIMAL SUBCUTANEOUS DOSES OF TOCILIZUMAB IN CHILDREN WITH POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS
    Jafri, Shazad
    Ramanan, Athimalaipet V.
    De Benedetti, Fabrizio
    Ruperto, Nicolino
    Lovell, Daniel
    Cuttica, Ruben
    Weiss, Jennifer E.
    Henrickson, Michael
    Schmeling, Heinrike
    Anton, Jordi
    Minden, Kirsten
    Hsu, Joy
    Bharucha, Kamal
    Wimalasundera, Sunethra
    Kadva, Alysha K.
    Upmanyu, Ruchi
    Mallalieu, Navita L.
    Martini, Alberto
    Brunner, Hermine
    [J]. RHEUMATOLOGY, 2017, 56 : 4 - 4
  • [6] Identification of Optimal Subcutaneous Doses of Tocilizumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis
    Brunner, Hermine
    Ruperto, Nicola
    Martini, Alberto
    Ramanan, Athimalaipet
    Cuttica, Ruben
    Weiss, Jennifer E.
    Henrickson, Michael
    Schmeling, Heinrike
    Anton, Jordi
    Minden, Kirsten
    Hsu, Joy
    Bharucha, Kamal
    Wimalasundera, Sunethra
    Kadva, Alysha K.
    Upmanyu, Ruchi
    Mallalieu, Navita L.
    Lovell, Daniel
    De Benedetti, Fabrizio
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 59 - 60
  • [7] Identification of Optimal Subcutaneous Doses of Tocilizumab in Children with Polyarticular-Course Juvenile Idiopathic Arthritis
    Brunner, Hermine I.
    Ruperto, Nicola
    Martini, Alberto
    Ramanan, Athimalaipet V.
    Cuttica, Ruben
    Weiss, Jennifer E.
    Henrickson, Michael
    Schmeling, Heinrike
    Anton, Jordi
    Minden, Kirsten
    Hsu, Joy
    Bharucha, Kamal
    Wimalasundera, Sunethra
    Kadva, Alysha K.
    Upmanyu, Ruchi
    Mallalieu, Navita L.
    Douglass, Wendy
    Lovell, Daniel J.
    De Benedetti, Fabrizio
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [8] IDENTIFICATION OF OPTIMAL SUBCUTANEOUS (SC) DOSES OF TOCILIZUMAB IN CHILDREN WITH POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS (PCJIA)
    De Benedetti, F.
    Ruperto, N.
    Lovell, D.
    Ramanan, A. V.
    Cuttica, R.
    Weiss, J. E.
    Henrickson, M.
    Schmeling, H.
    Anton, J.
    Minden, K.
    Hsu, J.
    Bharucha, K.
    Wimalasundera, S.
    Kadva, A. K.
    Upmanyu, R.
    Mallalieu, N. L.
    Martini, A.
    Brunner, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 396 - 396
  • [9] IMPROVEMENT IN PATIENT-REPORTED OUTCOMES IN PATIENTS WITH POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGIC OR NON-BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS TREATED WITH SC ABATACEPT
    Ruperto, N.
    Brunner, H.
    Tzaribachev, N.
    Vega-Cornejo, G.
    Louw, I.
    Anton, J.
    Viola, D.
    Foeldvari, I.
    Keltsev, V.
    Kingsbury, D.
    Wouters, C.
    Lauwerys, B.
    Alemao, E.
    Wong, R.
    Nys, M.
    Banerjee, S.
    Martini, A.
    Lovell, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 75 - 75
  • [10] Patient-Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two-Year Results From an International Phase III Study
    Ruperto, Nicolino
    Lovell, Daniel J.
    Berman, Alberto
    Avila-Zapata, Francisco
    Horneff, Gerd
    Alessio, Maria
    Becker, Mara L.
    Belot, Alexandre
    Burgos-Vargas, Ruben
    Gamir, Maria L.
    Goldenstein-Schainberg, Claudia
    Scheibel, Iloite M.
    Terreri, Maria T.
    Zemel, Lawrence
    Zhuo, Joe
    Askelson, Margarita
    Wong, Robert
    Martini, Alberto
    Brunner, Hermine I.
    [J]. ARTHRITIS CARE & RESEARCH, 2023, : 1804 - 1814